New hope pill tested for kids with Tough-to-Treat cancers
Disease control
Recruiting now
This study is testing a new oral medication called LAM561 for children under 18 with advanced, hard-to-treat cancers, including aggressive brain tumors. The main goals are to find a safe daily dose and see how well the body handles the drug. If the treatment shows benefit, childr…
Phase: PHASE1, PHASE2 • Sponsor: Laminar Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC